Lenalidomide (Revlimid) for anemia of myelodysplastic syndrome.
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D002872:Chromosome Deletion; D002895:Chromosomes, Human, Pair 5; D000075202:Contraindications; D005260:Female; D006801:Humans; D000077269:Lenalidomide; D009190:Myelodysplastic Syndromes / Q000150:complications / Q000188:drug therapy* / Q000235:genetics; D011247:Pregnancy; D011248:Pregnancy Complications; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D065227:Transfusion Reaction
D013792:Thalidomide; D000077269:Lenalidomide